Boundless Bio, Inc. BOLD
2.66
0.06
2.31%
as of 25 Sep
- Market cap
- $59.1M
- P/E
- 0.0×
Follow BOLD
Insider Buys
alert about insiders buying in the last 12 month
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | |
|---|---|---|---|---|
Current Ratio |
8.74 | 18.98 | 13.27 | 8.80 |
Net Debt/EBITDA |
0.99 | 1.45 | 2.24 | 1.40 |
Debt/Assets |
29.20% | 23.08% | 0.00% | 3.70% |
Debt/Equity |
0.46 | 0.32 | 0.00 | 0.04 |
Asset Turnover |
0.00 | 0.00 | 0.00 | — |
Operating CF/Net income |
0.80 | 0.93 | 0.95 | 0.86 |
Capex/Depreciation |
(0.44) | (2.34) | (0.66) | (1.13) |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 |
| (46.69%) | (554.86%) | 47.36% | 0.00% | |
| (32.02%) | (38.87%) | (47.83%) | 0.00% | |
ROIC |
(107.52%) | (99.20%) | 0.00% | (1,221.33%) |
Return on Tangible Assets |
(58.03%) | (43.41%) | (42.10%) | (72.59%) |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(2.11) | (3.73) | (39.05) | (37.03) |
Cash per Share |
4.81 | 8.96 | 99.30 | 60.76 |
Shareholders Equity per Share |
4.41 | 8.87 | 99.12 | 60.34 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
4.41 | 8.87 | 99.12 | 60.34 |
Free Cash Flow |
(47.21) | (63.38) | (47.49) | (40.66) |
Working Capital |
97.07 | 146.26 | 114.85 | 60.31 |
Capital Expenditures |
(0.55) | (2.54) | (0.63) | (1.07) |
Net Current Asset Value |
51.21 | 98.62 | 114.85 | 57.46 |
| Other line items | ||||
Quick Ratio |
8.58 | 18.70 | 12.90 | 8.63 |
Depreciation/Fixed assets |
0.39 | 0.25 | 0.37 | 0.32 |
Cash ROIC |
(19.78%) | (18.60%) | (20.49%) | (31.31%) |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(2.09) | (3.58) | (38.53) | (36.06) |
Capex per Share |
(0.02) | (0.15) | (0.52) | (0.97) |
Average Payables |
6.04 | 4.81 | 3.55 | — |
Average Assets |
181.73 | 168.15 | 103.36 | — |
Average Common Equity |
124.65 | 11.78 | (104.39) | — |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates